FDA Approves Rexulti For Agitation Associated With Dementia Due To Alzheimer's

RTTNews | 889日前
FDA Approves Rexulti For Agitation Associated With Dementia Due To Alzheimer's

(RTTNews) - The U.S. Food and Drug Administration announced the supplemental approval of Rexulti (brexpiprazole) oral tablets to treat agitation associated with dementia due to Alzheimer's disease. This is the first FDA-approved treatment option for this indication.

The supplemental approval of Rexulti was granted to Otsuka Pharmaceutical Co. Ltd., and Lundbeck Inc. Rexulti was discovered by Otsuka and is being co-developed by Otsuka and Lundbeck.

Dementia is a serious and debilitating neurological condition characterized by progressive decline in one or more cognitive domains in the brain. Dementia can seriously impair an individual's ability to function independently. Alzheimer's disease, the most common cause of dementia, is an irreversible, progressive brain disorder affecting more than 6.5 million Americans.

The agency's decision was based on two 12-week, randomized, double-blind, placebo-controlled, fixed-dose studies, which determined the effectiveness of Rexulti for the treatment of agitation associated with dementia due to Alzheimer's disease.

The recommended starting dosage for the treatment of such agitation is 0.5 mg taken once daily on days 1 to 7. Patients should increase the dosage on days 8 through 14 to 1 mg once daily, and on day 15 to 2 mg once daily. The recommended target dose is 2 mg once daily, and can be increased to the maximum recommended daily dosage of 3 mg once daily after at least 14 days, based on clinical response and tolerability.

On April 17, an FDA panel, which reviewed REXULTI, voted 9 to 1 that the companies provided sufficient data to allow the identification of a population in whom the benefits of treating agitation associated with Alzheimer's dementia with the drug outweighed its risks.

The FDA granted this application Fast Track designation, a process designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need.

Rexulti is already approved in the U.S. as an adjunctive therapy to antidepressants in adults with major depressive disorder and as a treatment for schizophrenia in adults.

Tiffany Farchione, director of the Division of Psychiatry in the FDA's Center for Drug Evaluation and Research, said, "Agitation is one of the most common and challenging aspects of care among patients with dementia due to Alzheimer's disease. 'Agitation' can include symptoms ranging from pacing or restlessness to verbal and physical aggression. These symptoms are leading causes of assisted living or nursing home placement and have been associated with accelerated disease progression."

For More Such Health News, visit rttnews.com

read more
Swiss Market Ends Modestly Lower

Swiss Market Ends Modestly Lower

The Switzerland market ended weak on Friday, in line with markets across Europe, as concerns about the health of U.S. regional banks hurt sentiment and triggered a sell-off in financials stocks across the globe.
RTTNews | 2時33分前
TSX Down Sharply; Materials Stocks Tumble

TSX Down Sharply; Materials Stocks Tumble

The Canadian market is down sharply in negative territory Friday afternoon due to a sell-off in materials stocks. Concerns about growth after Bank of Canada Governor Tiff Maclem warned that spillovers from U.S. President Donald Trump's tariff policies could weaken the economy.
RTTNews | 3時33分前
Bay Street Headed For Weak Start

Bay Street Headed For Weak Start

Lower Canadian and U.S. futures amid worries about the health of US regional banks, and lingering concerns about U.S.-China trade tensions point to a weak start for the Canadian market on Friday.
RTTNews | 7時49分前
FTSE 100 Down 1.4%; Bank Stocks Fall On U.S. Lenders' Credit Woes

FTSE 100 Down 1.4%; Bank Stocks Fall On U.S. Lenders' Credit Woes

The UK market is down sharply on Friday, hurt by a sell-off in the financials sector amid concerns about the health of U.S. banks after a couple of regional banks disclosed that they were exposed to alleged fraud by borrowers, spreading jitters about credit market turmoil.
RTTNews | 9時10分前
Pound Falls Amid BoE Rate Cut Speculation

Pound Falls Amid BoE Rate Cut Speculation

The British pound weakened against other major currencies in the European session on Friday, amid rising expectations that the Bank of England (BoE) will cut interest rates further this year.
RTTNews | 9時49分前